Martin Roper, CEO of Vita Coco (COCO), recently sold 25,000 shares of common stock for approximately $1.25 million, as reported in an SEC Form 4 filing. The sale, executed at a weighted average price of $50 per share, reflects Roper’s strategy to monetize gains while still maintaining a significant equity position, with nearly 1 million shares held directly and indirectly after the transaction.
This move comes amid a strong performance for Vita Coco, whose stock surged 52.48% over the past year, peaking at $61.39 in March. The company reported a robust 18% year-over-year revenue increase in 2025, driven by a 26% rise in sales of its flagship coconut water product. Despite the impressive growth, the stock’s forward price-to-earnings ratio of around 30 suggests it may be overvalued, prompting some analysts to recommend that current shareholders consider selling.
Investors should view Roper’s sale as a routine transaction under a Rule 10b5-1 plan, rather than a signal of declining confidence. However, potential buyers may want to exercise caution and wait for a more favorable entry point.
Source: fool.com